» Articles » PMID: 34307410

Empty Sella Syndrome As a Window Into the Neuroprotective Effects of Prolactin

Overview
Specialty General Medicine
Date 2021 Jul 26
PMID 34307410
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of this study was to relate diffusion MR measures of white matter integrity of the retinofugal visual pathway with prolactin levels in a patient with downward herniation of the optic chiasm secondary to medical treatment of a prolactinoma. A 36-year-old woman with a prolactinoma presented with progressive bilateral visual field defects 9 years after initial diagnosis and medical treatment. She was diagnosed with empty-sella syndrome and instructed to stop cabergoline. Hormone testing was conducted in tandem with routine clinical evaluations over 1 year and the patient was followed with diffusion magnetic resonance imaging (dMRI), optical coherence tomography (OCT), and automated perimetry at three time points. Five healthy controls underwent a complementary battery of clinical and neuroimaging tests at a single time point. Shortly after discontinuing cabergoline, diffusion metrics in the optic tracts were within the range of values observed in healthy controls. However, following a brief period where the patient resumed cabergoline (of her own volition), there was a decrease in serum prolactin with a corresponding decrease in visual ability and increase in radial diffusivity ( < 0.001). Those measures again returned to their baseline ranges after discontinuing cabergoline a second time. These results demonstrate the sensitivity of dMRI to detect rapid and functionally significant microstructural changes in white matter tracts secondary to alterations in serum prolactin levels. The inverse relations between prolactin and measures of white matter integrity and visual function are consistent with the hypothesis that prolactin can play a neuroprotective role in the injured nervous system.

Citing Articles

Investigating the relationship between cognitive impairment and brain white matter tracts using diffusion tensor imaging in patients with prolactinoma.

Duru M, Demir A, Oz A, Kargin O, Altunc A, Demirel O J Endocrinol Invest. 2024; 48(2):345-355.

PMID: 39361237 PMC: 11785683. DOI: 10.1007/s40618-024-02442-y.


TEMPORAL LOBE HERNIATION AND CHIASMOPATHY DURING DOPAMINE AGONIST THERAPY FOR PROLACTINOMA.

Giraldi E, Saindane A, Pradilla G, Biousse V, Ioachimescu A Acta Endocrinol (Buchar). 2024; 19(3):339-344.

PMID: 38356985 PMC: 10863970. DOI: 10.4183/aeb.2023.339.


Prolactin at moderately increased levels confers a neuroprotective effect in non-secreting pituitary macroadenomas.

Paul D, Rodrigue A, Contento N, Haber S, Hoang R, Rahmani R PLoS One. 2022; 17(8):e0271690.

PMID: 35921360 PMC: 9348739. DOI: 10.1371/journal.pone.0271690.

References
1.
Cobb M, Crowson M, Mintz-Cole R, Husain A, Berger M, Jang D . Transnasal Transsphenoidal Elevation of Optic Chiasm in Secondary Empty Sella Syndrome Following Prolactinoma Treatment. World Neurosurg. 2018; 112:250-253. DOI: 10.1016/j.wneu.2018.01.202. View

2.
Danesh-Meyer H, Carroll S, Foroozan R, Savino P, Fan J, Jiang Y . Relationship between retinal nerve fiber layer and visual field sensitivity as measured by optical coherence tomography in chiasmal compression. Invest Ophthalmol Vis Sci. 2006; 47(11):4827-35. DOI: 10.1167/iovs.06-0327. View

3.
Paul D, Gaffin-Cahn E, Hintz E, Adeclat G, Zhu T, Williams Z . White matter changes linked to visual recovery after nerve decompression. Sci Transl Med. 2014; 6(266):266ra173. PMC: 4292937. DOI: 10.1126/scitranslmed.3010798. View

4.
Trip S, Schlottmann P, Jones S, Li W, Garway-Heath D, Thompson A . Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage. 2006; 31(1):286-93. DOI: 10.1016/j.neuroimage.2005.11.051. View

5.
Porciatti V, Ciavarella P, Ghiggi M, DAngelo V, Padovano S, Grifa M . Losses of hemifield contrast sensitivity in patients with pituitary adenoma and normal visual acuity and visual field. Clin Neurophysiol. 1999; 110(5):876-86. DOI: 10.1016/s1388-2457(99)00024-3. View